Possibilities of allergic reaction therapy in pediatric practice
Authors:
- A. M. ZakirovaAZA. M. Zakirova
- T. G. MalanichevaTMT. G. Malanicheva
- G. Sh. MansurovaGMG. Sh. Mansurova
- L. N. SadrievaLSL. N. Sadrieva
- A. G. KadrievAKA. G. Kadriev
- I. N. SerdinskayaISI. N. Serdinskaya
- E. L. RashitovaERE. L. Rashitova
- A. I. KliushkinaAKA. I. Kliushkina
- I. R. ZaripovIZI. R. Zaripov
- D. A. KadrievDKD. A. Kadriev
Open Access
- 2 March 2022
- journal article
- research article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 166-176
Abstract
Introduction. Allergic diseases are a global medical and social problem due to the adverse effect on the physical, psychological and social state of a person. The basic principle of pharmacological therapy of acute allergic diseases is acute urticaria, angioedema (Quincke) – control/elimination of syndromic complexes.Aim. To evaluate the clinical efficacy of the antihistamine dimetindene in the treatment of acute allergic reactions in children.Materials and methods. We analyzed 36 patients aged 3 to 17 years with diagnoses of acute urticaria and acute urticaria with angioedema in a state of moderate severity. Patients felt a violation of the general condition – malaise (88.89%), chills/fever (5.56% and 8.34%, respectively), joint pain (2.78%). All patients underwent general clinical, laboratory and instrumental examination with subsequent analysis of the data obtained. To assess the response to treatment, UAS 7, the CU-Q2oL quality of life questionnaire were used.Results and discussion. The article discusses the main aspects of acute urticaria and angioedema, as the most common nosological forms in patients with atopy. The features of antihistamine therapy and its influence on the stages of the inflammation process are analyzed. The level of eosinophilia in the general blood test (median and interquartile range) was 6.5% (1.3%; 19.1%). An increase in total IgE was recorded in 80.56% of patients. The burden of allergic history was revealed in 86.12% of patients. By the end of the 1st day of treatment, symptoms were absent in every tenth patient (χ2 = 1.2461, p = 0.0865), remained in everyfifth child (χ2 = 53.6152, p = 0.0057) and significantly decreased in 2/3 children under study (χ2 = 59.6281, p = 0.0062). By the end of the 3rd day of therapy with dimetindene in the complex of treatment of acute urticaria and angioedema, a statistically significant improvement in clinical dynamics was recorded (χ2 = 102.1364, p = 0.0041) in the combined assessment of symptoms in 4/5 of the subjects and a decrease in discomfort associated with sleep in the overwhelming majority of the subjects (χ2 =51.4627, p = 0.0036).Conclusion. As a result of our own research on the use of dimetindene in patients with acute allergic reactions, it was shown that dimethindene has characteristics that meet the requirements for the exposure of the therapeutic effect, the level of effectiveness and the safety profile.Keywords
This publication has 13 references indexed in Scilit:
- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticariaAllergy, 2018
- Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines ProjectAllergy, 2017
- Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revisionJournal of Allergy and Clinical Immunology, 2017
- Respiratory comorbidity in South African children with atopic dermatitisSouth African Medical Journal, 2017
- The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSUAllergy, 2017
- Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysisBritish Journal of Dermatology, 2016
- Patient-reported impact of chronic urticaria compared with psoriasis in theUnited StatesJournal of Dermatological Treatment, 2016
- The Impact of Chronic Urticaria from the Patient’s Perspective: A Survey in Five European CountriesThe Patient - Patient-Centered Outcomes Research, 2015
- Increasing prevalence of asthma, respiratory symptoms, and allergic diseases: Four repeated surveys from 1993-2014Respiratory Medicine, 2015
- Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MASPediatric Allergy and Immunology, 2015